Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 6Myeloid 5Lymphoid 4Plasma cell 2Other neoplasm 2Classical hematology 2

Conditions

Multiple Myeloma 85Leukemia, Lymphocytic, Chronic, B-Cell 71Hodgkin Disease 67Precursor Cell Lymphoblastic Leukemia-Lymphoma 64Lymphoma, Non-Hodgkin 60Leukemia, Myeloid, Acute 59Myelodysplastic Syndromes 53Lymphoma, Mantle-Cell 52Lymphoma, Follicular 52Lymphoma, Large B-Cell, Diffuse 47Lymphoma, B-Cell, Marginal Zone 47Burkitt Lymphoma 42Myeloproliferative Disorders 40Lymphoma, Large-Cell, Immunoblastic 38Lymphoma 37Leukemia 37Leukemia, Myeloid, Chronic-Phase 35Congenital Abnormalities 35Neoplasms, Plasma Cell 33Leukemia, Myelomonocytic, Chronic 31Leukemia, Myelogenous, Chronic, BCR-ABL Positive 31Waldenstrom Macroglobulinemia 29Primary Myelofibrosis 29Leukemia, Myeloid, Accelerated Phase 28Dendritic Cell Sarcoma, Interdigitating 27Recurrence 25Lymphoma, T-Cell, Cutaneous 24Sezary Syndrome 23Mycosis Fungoides 23Lymphoma, Large-Cell, Anaplastic 22

Interventions

fludarabine 3thymoglobulin 2Whole-Body Irradiation 2Tacrolimus 2Sirolimus 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Cyclophosphamide 2Busulfan 2Behavior Therapy 2methanesulfonic acid 1fludarabine phosphate 1Stem Cell Transplantation 1Social Determinants of Health 1Methotrexate 1Melphalan 1Immunotherapy, Adoptive 1Granulocyte Colony-Stimulating Factor 1Dasatinib 1Antilymphocyte Serum 1Allopurinol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Leukemia, Myeloid × Mycophenolic Acid × Plasma cell × Clear all
NCT01760655 2025-10-30

Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies

Thomas Jefferson University

Phase 2 Completed
62 enrolled 15 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Hodgkin Disease, Leukemia, Myeloid, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Polycythemia Vera, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Primary Myelofibrosis

NCT05805605 2025-07-01

Allo HSCT Using RIC and PTCy for Hematological Diseases

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
56 enrolled
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Burkitt Lymphoma, Leukemia, Myeloid, Leukemia, Plasma Cell, Lymphoma, Follicular, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Prolymphocytic, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, T-Cell, Lymphoma, B-Cell, Marginal Zone, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡